- Anxiety trajectories among cancer survivors during the COVID-19 pandemic: This study used a longitudinal survey to examine the trajectories of general and bodily vigilance anxiety among cancer survivors during the COVID-19 pandemic, and to evaluate associated factors such as fear of cancer recurrence, loneliness, and emotional approach coping. Latent class growth analyses revealed three distinct trajectories for general anxiety and two for bodily vigilance anxiety.
- Nighttime continuous contactless smartphone-based cough monitoring for the ward: A validation study: Mobile technologies such as wearables and smartphones can be used to monitor clinical deterioration on hospital wards by detecting subtle changes in vital signs, such as cough. This could help detect health deterioration earlier and improve patient outcomes.
- Comparative effectiveness of different primary vaccination courses on mRNA-based booster vaccines against SARs-COV-2 infections: a time-varying cohort analysis using trial emulation in the Virus Watch: The UK’s booster vaccination programme used mRNA vaccines to tackle infections caused by the Omicron B.1.1.529 variant, regardless of an individual’s primary course vaccine type. The programme prioritized the clinically vulnerable, and was successful in reducing SARS-CoV-2 infections in doubly vaccinated individuals.
- Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients: Vaccinated patients had lower anti-N antibody responses in their plasma and oral fluid after SARS-CoV-2 infection compared to those infected before vaccination or without vaccination, raising questions about the long-term use of anti-N antibodies as a marker for natural infection for surveillance.
- Nighttime continuous contactless smartphone-based cough monitoring for the ward: A validation study: Mobile technologies such as wearables and smartphones can be used to monitor patients on hospital wards by detecting subtle changes in vital signs, such as coughing. Coughing can be a predictor of acute health deterioration and can help detect clinical deterioration earlier.
- [Advances in epidemiology, etiology, and treatment of community-acquired pneumonia]: This article reviews the epidemiological characteristics, pathogen spectrum and treatment direction of community-acquired pneumonia (CAP) in China over time, with a focus on the emergence of unconventional treatment strategies due to the COVID-19 outbreak.
- A comparison of post-COVID vaccine myocarditis classification using the Brighton Collaboration criteria versus Centre for Disease Control criteria
- Patients With Mild COVID-19 at Risk of Some Post-COVID-19 Condition Symptoms
- Self-Perceived Halitosis and Related Factors Among the Mask-Wearing Population During the COVID-19 Pandemic in Delhi, India: A Cross-Sectional Study: This study aimed to determine the prevalence of self-perceived halitosis (SPH) among mask-wearing patients visiting a tertiary care dental hospital in India.
- Large interfacial relocation in RBD-ACE2 complex may explain fast-spreading property of Omicron: Simulations of the interactions between the Omicron variant of SARS-CoV-2 and human ACE2 show that the Omicron variant has increased binding affinity to human ACE2, which may explain its fast-spreading properties.
- The influence of new SARS-CoV-2 variant Omicron (B.1.1.529) on vaccine efficacy, its correlation to Delta variants: A computational approach: The newly discovered COVID variant B.1.1.529 in Botswana has more than 30 mutations in its spike and other non-spike proteins, far more than any other SARS-CoV-2 variant accepted as a variant of concern by the WHO. Our findings provide insights into structural modifications caused by these mutations and their effects on interactions with the host’s neutralizing antibodies.
Daily News Pulse for April 05, 2023
April 5, 2023
Summary: The domestic box office is close to reaching pre-pandemic levels, with mid-budget films helping to bring moviegoers back. Research has found that diabetes is a major factor in the severity of COVID-19 cases. The US government is planning to authorize booster doses of the vaccine for high-risk populations.
